SMAD4 and neoplasm: For 13 stroma-specific mutations, there were only two driver events (15.4%, KRAS G12V for P05, SMAD4 W302* for P43, Table S1), while 57 driver events (42.5%) were underlined in 134 neoplasm-specific mutations.